Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Monday, February 06, 2017
Myoderm has announced the addition of Chief Operating Officer James Lovett. James will work alongside long-time Managing Director Michael Cohen to lead the company on a continued path of growth and global expansion.
read more
Monday, February 06, 2017
Innomar Strategies, a specialty drug service provider, and a part of AmerisourceBergen, is adding another distribution center and three specialty pharmacies to the company’s existing specialty solutions infrastructure. The new locations will further ...
read more
Monday, February 06, 2017
Cocoon Biotech, Inc., is a biotechnology company focused on utilizing its silk protein-based drug delivery technology for the development of formulations to treat osteoarthritis and other conditions for which many patients find existing treatments to...
read more
Monday, February 06, 2017
Veeva Systems has announced Veeva Vault Submissions Publishing, a new cloud application that seamlessly incorporates publishing capabilities within Veeva Vault RIM to speed regulatory submission delivery.
read more
Monday, February 06, 2017
Strata Oncology, a precision oncology company, has announced an agreement with Epizyme to support patient identification and enrollment for Epizyme's ongoing Phase 2 clinical trial of tazemetostat in patients with relapsed or refractory non-Hodgkins ...
read more
Monday, February 06, 2017
Quotient Clinical, an early phase drug development services provider, has acquired SeaView Research, expanding its operations into the USA. The acquisition combines Quotient and SeaView’s complementary customer portfolios, and strengthens the early ...
read more
Tuesday, February 07, 2017
Catalent, a global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, has announced financial results for the second quarter of fiscal year 2017, which ended December 31, 2016.
read more
Tuesday, February 07, 2017
AMRI has entered an alliance with Bruker Daltonics and HighRes Biosolutions to develop new applications for using high throughput mass spectrometry (MS) for drug discovery.
read more
Wednesday, February 08, 2017
Capsugel has announced the broad commercial availability of its Modular Automated Sampling Technology™ (MAST) system, which directly transfers samples from bioreactors to analytical devices while maintaining process sterility.
read more
Wednesday, February 08, 2017
Impel NeuroPharma, a Seattle-based clinical stage biotechnology company developing first-in-class intranasal drug treatments announced has entered into service agreements with Camargo Pharmaceutical Services, LLC ("Camargo").
read more
Wednesday, February 08, 2017
Acceliant, a provider of clinical trial management solutions, has received the prestigious World Health Organization (WHO) Drug Dictionaries Medical Coding certification. The WHO Drug Dictionary is an international classification of medicines used by...
read more
Wednesday, February 08, 2017
Quality Packaging Specialists International has acquired 100% ownership of International Labs in an equity exchange transaction. Terms of the transaction were not disclosed. INL, based in St. Petersburg, FL, delivers adherence packaging solutions for...
read more
Monday, February 13, 2017
Akebia Therapeutics, a biopharmaceutical company focused on delivering innovative therapies to patients through the biology of hypoxia-inducible factor (HIF), has entered into an exclusive agreement with Janssen Pharmaceutica, NV, one of the Janssen ...
read more
Monday, February 13, 2017
INC Research Holdings, Inc., a global Phase I to IV contract research organization, has announced the appointment of Eric Paul Pâques, previously the Chief Executive Officer for GRÜNENTHAL GROUP, to the Company’s Board of Directors.
read more
Monday, February 13, 2017
PAREXEL International Corporation, a global biopharmaceutical services provider, has launched a mobile app for the ClinPhone® RTSM (randomization and trial supply management) service. The app is designed to enhance clinical trial supply management ...
read more